JP Morgan Maintains Overweight on Aptiv, Raises Price Target to $113
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Ryan Brinkman maintains an Overweight rating on Aptiv and raises the price target from $107 to $113.
October 21, 2024 | 12:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan analyst Ryan Brinkman has maintained an Overweight rating on Aptiv and increased the price target from $107 to $113, indicating a positive outlook on the stock.
The increase in price target from $107 to $113 by a major financial institution like JP Morgan suggests a positive outlook on Aptiv's future performance. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100